Priority Date: 26.01.12 (US 201261632582P)

ANTIFIBROTIC COMPOUNDS AND USES THEREOF

  • Application ID: EP13740566
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1988
1154.4
Headquarter in London and 1 office
active in Legal Services, IP Consulting, Matchmaking and Trading, IP Portfolio Processing, IPR-related Financial Service, and IP-related Communication Service

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 233 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 26.01.2012 - Priority Date (US 201261632582P)
  • 01.08.2013 - Publication A1 (WO2013112959)
  • 03.12.2014 - Publication A1 (EP2807160)